Their research has led to the development of a promising new drug that could change the treatment landscape for this ...

Diabetes development is multifactorial and not solely determined by the amount of fat mass This sheds light on the reason why ...

Learn about the rising concern of fatty liver disease, risk factors, symptoms, prevention, and treatment options from an ...

The research team led by Dr. Hyunwoo Kim and Dr. Myungae Bae at the Korea Research Institute of Chemical Technology (KRICT) ...

The development of NAFLD is multifactorial, involving a genetic predisposition, insulin resistance, and metabolic syndrome components such as obesity, dyslipidemia, and hypertension.

At the moment, there is a lack of clinically relevant preclinical models for fatty liver disease. This problem has led to most drug candidates that were successful in preclinical development ...

Based on the association of CVD, diabetes and metabolic syndrome with the development and progression of NAFLD, the management of NAFLD should include aggressive management of cardiovascular risk ...

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. It encompasses a wide spectrum of liver lesions, from pure steatosis to end-stage liver disease with ...

Researchers have established in a new study that triglyceride-glucose (TyG) levels have a U-shaped correlation with the ...